Classifying EGFR mutations by structure offers better way to match non-small cell lung cancer patients to treatments

Researchers from The University of Texas MD Anderson Cancer Center have discovered that grouping epidermal growth factor receptor (EGFR) mutations by structure and function provides an accurate framework to match patients with non-small cell lung cancer (NSCLC) to the right drugs. The findings, published today in Nature, identify four subgroups of mutations and introduce a […]

Continue Reading

BAK/MCL1 complexes can predict chemotherapy drugs sensitivity in cancer cells

A research team led by Prof. Dai Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) recently announced the constitutive BAK/MCL1 complexes could predict chemotherapy drugs sensitivity of ovarian cancer. Result has been published in Cell Death & Disease. According to the activation and interaction status of BAK […]

Continue Reading

Real-time mammography reading cuts disparities in diagnostic imaging

An immediate-read screening mammography program reduces racial and ethnic disparities in same-day diagnostic imaging after abnormal screening mammograms, according to a study published online Sept. 8 in the American Journal of Roentgenology. Brian N. Dontchos, M.D., from Massachusetts General Hospital in Boston, and colleagues assessed the impact of an immediate-read screening program on disparities in […]

Continue Reading

2007 to 2021 saw dermatologic procedure reimbursement down

From 2007 to 2021, there was a mean decrease of −4.8 percent in dermatologic procedure reimbursement overall, according to a study published online Sept. 15 in JAMA Dermatology. Rishabh S. Mazmudar, from Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a cross-sectional study using reimbursement data from the Centers for Medicare […]

Continue Reading